Market Cap 139.00M
Revenue (ttm) 40,000.00
Net Income (ttm) -11.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28,600.00%
Debt to Equity Ratio 0.00
Volume 244,900
Avg Vol 3,139,770
Day's Range N/A - N/A
Shares Out 49.29M
Stochastic %K 16%
Beta 1.38
Analysts Sell
Price Target $9.00

Company Profile

Entera Bio Ltd., a clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally. It develops EB613, an oral teriparatide, which completed the Phase II clinical trial for the treatment of osteoporosis and Phase I clinical trial for the treatment of stress fractures. The company is also involved in the development of EB612, a tablet peptide replacement therapy, which is in Phase I clinical trial for the treatment of hypoparathy...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 2 532 7151
Address:
Kiryat Hadassah Minrav Building, 5th Floor, Jerusalem, Israel
WallStWireAds
WallStWireAds Aug. 7 at 8:10 PM
$ENTX https://www.globenewswire.com/news-release/2026/08/07/3341389/0/en/entera-announces-second-quarter-2026-financial-results-and-busines
0 · Reply
charliewheels
charliewheels Aug. 4 at 8:15 PM
$ENTX hoping for a large bounce here. ??
0 · Reply
SuperSuper
SuperSuper Aug. 4 at 5:30 PM
$ENTX Let’s be realistic about what the recent ENTX and ALT offerings actually mean. Comparing them as a sign of "superior negotiation" misses the bigger picture: Market Cap vs. Raise Size Reality: ENTX has a market cap under $150M. Praising a massive structural setup without acknowledging the massive dilution relative to its tiny size ignores basic fundamentals. Warrants as Risk Management: Calling out ALT for tying warrants to Phase 3 MASH data misses the point. In clinical-stage biotech, milestone-linked warrants or tranches are standard risk management for institutional investors backing high-stakes catalysts. Bullish Bias: Don't let hyper-bullish sentiment blind you to how these financing terms impact current shareholders in the long run. $ALT
1 · Reply
Groggok
Groggok Aug. 4 at 5:17 PM
$ALT ALT management — take notes. This is how you raise money. $ENTX just priced a $275M oversubscribed placement at $2.04, straight shares and pre-funded warrants, zero accompanying warrant coverage. No toxic overhang, no capped upside, no permanent overhang seller lurking for years. Compare that to ALT’s $225M raise — a full 1:1 warrant tranche at $3.00 that doesn’t clear until 45 days past Phase 3 MASH data. Same oversubscribed demand, wildly different discipline at the negotiating table. Durso’s been touting “non-dilutive funding” and partnership options for months — I hope this time he actually delivers, because the last raise sure didn’t look like it! https://finance.yahoo.com/healthcare/articles/entera-bio-announces-pricing-oversubscribed-123000084.html
0 · Reply
RunningRobert1
RunningRobert1 Aug. 4 at 1:52 PM
$ENTX does anybody have the final share count after the private placement?
0 · Reply
WallStWireAds
WallStWireAds Aug. 4 at 12:34 PM
$ENTX https://www.globenewswire.com/news-release/2026/08/04/3338306/0/en/Entera-Bio-Phase-2-Data-Supporting-EB613-s-Oral-PTH-1-34-Anabolic-
0 · Reply
Anonymous10000
Anonymous10000 Aug. 4 at 1:21 AM
$ENTX if you are looking for a stock with a near term catalyst, come to $SLS https://seekingalpha.com/article/4922043-sellas-life-sciences-strong-buyimminent-catalyst-dual-platform-pipeline-and-a-market-that-hasnt-caught-up
0 · Reply
Vicccccc
Vicccccc Aug. 3 at 11:45 AM
$ENTX Let’s see if we get lucky today and it manages to break above the $3.20 level from last Friday. 🤞
0 · Reply
Vicccccc
Vicccccc Aug. 3 at 5:08 AM
$ENTX Overnight $3,12 🍀🙏🏻
0 · Reply
Zeestallion
Zeestallion Aug. 2 at 8:47 PM
VIVS - This one is 🔥🥵🌡🚀⏲️💣🚢 Eli Lilly a TRILLION dollar pharmaceutical company backing this project. ✅ Liver: 91% accuracy | 100% specificity ✅ GI: 96% accuracy | 97% sensitivity ✅ Already validated on ADCs ✅️ Liver and GI models show high in ADCs ✅️ Their lab models are better at predicting real human side effects than the old animal tests. That's why big pharma is starting to pay attention. ✅️ Eli Lilly knows this is a game changer for big pharma companies $MGRX $AMIX $LVWR $ENTX
1 · Reply
Latest News on ENTX
Entera Bio Quarterly report: Q2 2026

Aug 7, 2026, 7:00 AM EDT - 19 hours ago

Entera Bio Quarterly report: Q2 2026


Entera Bio Earnings release: Q2 2026

Aug 7, 2026, 7:00 AM EDT - 19 hours ago

Entera Bio Earnings release: Q2 2026


Entera Bio announces $275M private placement

2026-07-27T12:50:08.000Z - 11 days ago

Entera Bio announces $275M private placement


Entera Bio Proxy statement: Proxy filing

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Entera Bio Proxy statement: Proxy filing


Entera Bio Proxy statement: Proxy filing

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Entera Bio Proxy statement: Proxy filing


Entera Bio Proxy statement: Proxy filing

May 14, 2026, 8:00 AM EDT - 3 months ago

Entera Bio Proxy statement: Proxy filing


Entera Bio files to sell 19.57M ordinary shares for holders

2026-05-08T22:57:48.000Z - 3 months ago

Entera Bio files to sell 19.57M ordinary shares for holders


Entera Bio Registration statement: Registration filing

May 8, 2026, 8:00 AM EDT - 3 months ago

Entera Bio Registration statement: Registration filing


Entera Bio Quarterly report: Q1 2026

May 8, 2026, 7:00 AM EDT - 3 months ago

Entera Bio Quarterly report: Q1 2026


Entera Bio Earnings release: Q1 2026

May 8, 2026, 7:00 AM EDT - 3 months ago

Entera Bio Earnings release: Q1 2026


Entera Bio Transcript: KOL event

Apr 20, 2026, 11:00 AM EDT - 3 months ago

Entera Bio Transcript: KOL event


Entera Bio Annual report: Q4 2025

Mar 27, 2026, 7:30 AM EDT - 4 months ago

Entera Bio Annual report: Q4 2025


Entera Bio Earnings release: Q4 2025

Mar 27, 2026, 7:30 AM EDT - 4 months ago

Entera Bio Earnings release: Q4 2025


Entera Bio Slides: Corporate presentation

Mar 11, 2026, 7:00 AM EDT - 5 months ago

Entera Bio Slides: Corporate presentation


Entera Bio appoints Geno Germano as chairman of the board

2026-02-09T14:00:34.000Z - 6 months ago

Entera Bio appoints Geno Germano as chairman of the board

PFE


Entera Bio announces expected milestones for Q1 in 2026

2026-01-21T13:35:26.000Z - 7 months ago

Entera Bio announces expected milestones for Q1 in 2026


Entera Bio announces new data on long-acting PTH tablet

2025-12-22T13:41:31.000Z - 8 months ago

Entera Bio announces new data on long-acting PTH tablet


Entera Bio Earnings release: Q3 2025

Nov 14, 2025, 4:00 PM EST - 9 months ago

Entera Bio Earnings release: Q3 2025


Entera Bio Quarterly report: Q3 2025

Nov 14, 2025, 4:00 PM EST - 9 months ago

Entera Bio Quarterly report: Q3 2025


Entera Bio presents clinical data from EB613 Phase 2 trial

2025-10-23T12:55:37.000Z - 10 months ago

Entera Bio presents clinical data from EB613 Phase 2 trial


Entera Bio Earnings release: Q2 2025

Aug 8, 2025, 7:00 AM EDT - 1 year ago

Entera Bio Earnings release: Q2 2025


Entera Bio Quarterly report: Q2 2025

Aug 8, 2025, 7:00 AM EDT - 1 year ago

Entera Bio Quarterly report: Q2 2025


Entera Bio Slides: Corporate Presentation

Jul 2, 2025, 2:21 PM EDT - 1 year ago

Entera Bio Slides: Corporate Presentation


Entera Bio Proxy statement: Proxy Filing

Jun 5, 2025, 8:00 AM EDT - 1 year ago

Entera Bio Proxy statement: Proxy Filing


Entera Bio Proxy statement: Proxy Filing

Jun 5, 2025, 8:00 AM EDT - 1 year ago

Entera Bio Proxy statement: Proxy Filing


Entera Bio Registration statement: Registration Filing

May 30, 2025, 8:00 AM EDT - 1 year ago

Entera Bio Registration statement: Registration Filing


Entera Bio Proxy statement: Proxy Filing

May 14, 2025, 8:00 AM EDT - 1 year ago

Entera Bio Proxy statement: Proxy Filing


Entera Bio Earnings release: Q1 2025

May 9, 2025, 4:00 PM EDT - 1 year ago

Entera Bio Earnings release: Q1 2025


Entera Bio Quarterly report: Q1 2025

May 9, 2025, 4:00 PM EDT - 1 year ago

Entera Bio Quarterly report: Q1 2025


Entera Bio Annual report: Q4 2024

Mar 27, 2025, 7:00 PM EDT - 1 year ago

Entera Bio Annual report: Q4 2024


Entera Bio Earnings release: Q4 2024

Mar 27, 2025, 7:00 PM EDT - 1 year ago

Entera Bio Earnings release: Q4 2024


Entera Bio to Participate in Upcoming Events

Feb 24, 2025, 8:30 AM EST - 1 year ago

Entera Bio to Participate in Upcoming Events


Entera Bio Slides: Corporate Presentation

Jan 9, 2025, 7:00 AM EST - 1 year ago

Entera Bio Slides: Corporate Presentation


Entera Bio Quarterly report: Q3 2024

Nov 8, 2024, 7:00 AM EST - 1 year ago

Entera Bio Quarterly report: Q3 2024


Entera Bio Earnings release: Q3 2024

Nov 8, 2024, 7:00 AM EST - 1 year ago

Entera Bio Earnings release: Q3 2024


Entera Bio Earnings release: Q2 2024

Aug 9, 2024, 7:00 AM EDT - 2 years ago

Entera Bio Earnings release: Q2 2024


Entera Bio Quarterly report: Q2 2024

Aug 9, 2024, 7:00 AM EDT - 2 years ago

Entera Bio Quarterly report: Q2 2024


Entera Bio Proxy statement: Proxy Filing

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Entera Bio Proxy statement: Proxy Filing


Entera Bio Proxy statement: Proxy Filing

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Entera Bio Proxy statement: Proxy Filing


Entera Bio Proxy statement: Proxy Filing

May 29, 2024, 8:00 AM EDT - 2 years ago

Entera Bio Proxy statement: Proxy Filing


Entera Bio Earnings release: Q1 2024

May 10, 2024, 7:00 AM EDT - 2 years ago

Entera Bio Earnings release: Q1 2024


Entera Bio Quarterly report: Q1 2024

May 10, 2024, 7:00 AM EDT - 2 years ago

Entera Bio Quarterly report: Q1 2024


Entera Bio Annual report: Q4 2023

Mar 8, 2024, 7:00 AM EST - 2 years ago

Entera Bio Annual report: Q4 2023


Entera Bio Earnings release: Q4 2023

Mar 8, 2024, 7:00 AM EST - 2 years ago

Entera Bio Earnings release: Q4 2023


Entera Bio Registration statement: Registration Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

Entera Bio Registration statement: Registration Filing


Entera Bio Registration statement: Registration Filing

Feb 2, 2024, 7:00 AM EST - 2 years ago

Entera Bio Registration statement: Registration Filing


Entera Bio Earnings release: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

Entera Bio Earnings release: Q3 2023


Entera Bio Quarterly report: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

Entera Bio Quarterly report: Q3 2023


WallStWireAds
WallStWireAds Aug. 7 at 8:10 PM
$ENTX https://www.globenewswire.com/news-release/2026/08/07/3341389/0/en/entera-announces-second-quarter-2026-financial-results-and-busines
0 · Reply
charliewheels
charliewheels Aug. 4 at 8:15 PM
$ENTX hoping for a large bounce here. ??
0 · Reply
SuperSuper
SuperSuper Aug. 4 at 5:30 PM
$ENTX Let’s be realistic about what the recent ENTX and ALT offerings actually mean. Comparing them as a sign of "superior negotiation" misses the bigger picture: Market Cap vs. Raise Size Reality: ENTX has a market cap under $150M. Praising a massive structural setup without acknowledging the massive dilution relative to its tiny size ignores basic fundamentals. Warrants as Risk Management: Calling out ALT for tying warrants to Phase 3 MASH data misses the point. In clinical-stage biotech, milestone-linked warrants or tranches are standard risk management for institutional investors backing high-stakes catalysts. Bullish Bias: Don't let hyper-bullish sentiment blind you to how these financing terms impact current shareholders in the long run. $ALT
1 · Reply
Groggok
Groggok Aug. 4 at 5:17 PM
$ALT ALT management — take notes. This is how you raise money. $ENTX just priced a $275M oversubscribed placement at $2.04, straight shares and pre-funded warrants, zero accompanying warrant coverage. No toxic overhang, no capped upside, no permanent overhang seller lurking for years. Compare that to ALT’s $225M raise — a full 1:1 warrant tranche at $3.00 that doesn’t clear until 45 days past Phase 3 MASH data. Same oversubscribed demand, wildly different discipline at the negotiating table. Durso’s been touting “non-dilutive funding” and partnership options for months — I hope this time he actually delivers, because the last raise sure didn’t look like it! https://finance.yahoo.com/healthcare/articles/entera-bio-announces-pricing-oversubscribed-123000084.html
0 · Reply
RunningRobert1
RunningRobert1 Aug. 4 at 1:52 PM
$ENTX does anybody have the final share count after the private placement?
0 · Reply
WallStWireAds
WallStWireAds Aug. 4 at 12:34 PM
$ENTX https://www.globenewswire.com/news-release/2026/08/04/3338306/0/en/Entera-Bio-Phase-2-Data-Supporting-EB613-s-Oral-PTH-1-34-Anabolic-
0 · Reply
Anonymous10000
Anonymous10000 Aug. 4 at 1:21 AM
$ENTX if you are looking for a stock with a near term catalyst, come to $SLS https://seekingalpha.com/article/4922043-sellas-life-sciences-strong-buyimminent-catalyst-dual-platform-pipeline-and-a-market-that-hasnt-caught-up
0 · Reply
Vicccccc
Vicccccc Aug. 3 at 11:45 AM
$ENTX Let’s see if we get lucky today and it manages to break above the $3.20 level from last Friday. 🤞
0 · Reply
Vicccccc
Vicccccc Aug. 3 at 5:08 AM
$ENTX Overnight $3,12 🍀🙏🏻
0 · Reply
Zeestallion
Zeestallion Aug. 2 at 8:47 PM
VIVS - This one is 🔥🥵🌡🚀⏲️💣🚢 Eli Lilly a TRILLION dollar pharmaceutical company backing this project. ✅ Liver: 91% accuracy | 100% specificity ✅ GI: 96% accuracy | 97% sensitivity ✅ Already validated on ADCs ✅️ Liver and GI models show high in ADCs ✅️ Their lab models are better at predicting real human side effects than the old animal tests. That's why big pharma is starting to pay attention. ✅️ Eli Lilly knows this is a game changer for big pharma companies $MGRX $AMIX $LVWR $ENTX
1 · Reply
Vicccccc
Vicccccc Aug. 2 at 8:24 AM
$ENTX Do you guys think it can break through the $3.20 level we saw last Friday next week?🍀🙏🏻
1 · Reply
DiamondDelta
DiamondDelta Aug. 2 at 12:02 AM
If you are looking for the next big runner. Read below! RUBI can be the next explosive mover for next week. Big news+ 600k float. RUBI just getting started, we saw what it did Friday, now with more eyes this can go even higher. Hot market right now $VIVS $ZYBT $ADVB $ENTX //
0 · Reply
WallStWireAds
WallStWireAds Jul. 31 at 8:32 PM
$ENTX https://www.globenewswire.com/news-release/2026/07/31/3337062/0/en/Entera-Bio-to-Participate-in-the-Canaccord-Genuity-46th-Annual-Gro
0 · Reply
HUNTER40
HUNTER40 Jul. 31 at 6:44 PM
0 · Reply
Vicccccc
Vicccccc Jul. 31 at 6:02 PM
$ENTX 🙏🏻🙏🏻🙏🏻🙏🏻3,19
0 · Reply
Vicccccc
Vicccccc Jul. 31 at 5:48 PM
$ENTX 🙏🏻🙏🏻🍀🍀 $3,10 🍀🍀🙏🏻🙏🏻
0 · Reply
Vicccccc
Vicccccc Jul. 31 at 5:14 PM
$ENTX Please, don’t let it stop now! 🙏3.0199 🙏🏻🙏🏻🍀🍀
0 · Reply
Vicccccc
Vicccccc Jul. 31 at 4:25 PM
$ENTX It’s about to break $3. We just need to let it fly… A little more volume and we’ve got it! 🍀🤞🏼🍀🤞🏼🙏🏻🙏🏻
0 · Reply
Vicccccc
Vicccccc Jul. 31 at 3:56 PM
$ENTX I’ve just bought back in. Let’s see if my luck changes after these last two days. It started strongly today… Hopefully the volume comes in. With very little buying pressure, it could break above $3.20! Fingers crossed we get some luck today! 🚀🍀
0 · Reply
Vicccccc
Vicccccc Jul. 31 at 5:54 AM
$ENTX Good luck to everyone today! Hopefully $ENTX takes off and heads toward $4. I made some very hasty decisions yesterday and got out too soon. We’ve already seen $3.06 in the overnight session. Just bad luck on my part. I hope you guys have better luck today! 🚀🍀
0 · Reply
Zackpedia
Zackpedia Jul. 30 at 8:56 PM
$ENTX Down to 2.8, you could’ve bought back.
0 · Reply
jbh973
jbh973 Jul. 30 at 4:26 PM
IN MY DEFENSE Thanks to 20+ yrs of unplanned poverty, I didn't start investing until 2018. By 2019 I was back on my feet enough to invest 60% of my paychecks from 2 full time jobs. Short list of some tickers I bought & held, GILD-ABBV-XOM-MO-OKE-VZ-DUK to name but a few. My gamble tickers were of course more hit & miss,but buying LKNCY between .95 &$4 more than covered any misfires I had. My cost avgs on the above is a F'n portfolio wet dream. I am not rich by any means, however, not having to count the items in ones shopping cart is still a nice feeling in 2026. So to the grouchies who like to take pokes at my posts, nertz to you. To the rest, thanks for the shared knowledge that has helped me over the past 7 yrs. Time for THE MIDDAY STOCK MARKET REVIEW ( The better Eye of the tiger than a tiger by the tale Edition ) $LKNCY If this was spinach we'd all be Popeye. $DX Still adding on dip. $NGEN Lil worried but still adding. $ARDX Watching ice form. $ENTX Waiting to reenter...again.
1 · Reply